Cognitive Functions After TIVA With Dexmedetomidine

Sponsor
Uludag University (Other)
Overall Status
Completed
CT.gov ID
NCT02631135
Collaborator
(none)
40
1
2
9
4.4

Study Details

Study Description

Brief Summary

It is important to wake up without any problem and comfortably from the general anesthesia. The aim of this study is to investigate the effects of addition dexmedetomidine to the balanced intravenous anesthesia with propofol over the cognitive functions and also it is considered that the addition of dexmedetomidine would reduce the use of anesthetics drugs in TİVA. Together with this effects, it has been considered that the disorder of the cognitive functions in postoperative period and the need for anesthetic drugs in postoperative period will be less.

After the approval of the Ethics Committee and the patients being informed and taking informed consent from them 15 male 25 female totally 40 patients between the age of 20-60 years old, who had lumbar disc hernia, under general anesthesia have been taken under the study. The patients have been divided into two groups by closed envelope drawing method, randomly. All patients cognitive functions were evaluated by MMSE (Mini Mental State Examination) during the premedication visit. For this study group Standardized Mini Mental Test Examination (SMMT-E) were used, which has quite practical usage, for the untrained patients, and test composed of question-answer in order to calculate the remembering, caution and calculation structure and the scores were recorded. All patients had received the same anesthesia induction with propofol infusion (started at firstly 12 mg. kg-1 for the 30 minutes, the second 30 minutes 9 mg. kg-1 and the BIS(bispectral index) values were arranged between 40-60 until the end of the operation), and remifentanil infusion (0.5 μg.kg-1 was applied as opioid and was arranged according to the tension artery and heart rate). In the dexmedetomidine group, dexmedetomidine infusion had started as 0.5 μg.kg-1 without making the loading dose and the dose change was not made. Rocuronium 0.5 mg. kg-1 iv. was applied for the endotracheal intubation. After the operation all patients have taken to the recovery room.

Then the tests of cognitive function evaluation were repeated as postoperative 2nd hour, 24 hours, 1 week and 1 month.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

After the approve of the Ethics Committee and the patients were informed and taken informed consent form from them (15 male and 25 female) totally 40 patients between the age of 20-60 years old, who had lumbar disc hernia, under general anesthesia have been taken under the study. The patients with hepatic, renal or neurological diseases and using sedative- hypnotic, anticonvulsive and stimulant drugs and pregnant patients were excluded. Then they have been divided into two groups by closed envelope drawing method randomly and were allowed to stay hungry at least 8 hours. All the patients were applied the cognitive functions during the premedication visit MMSE (Mini Mental State Examination) that has quite practical usage and the test called Standardized Mini Mental Test Examination(SMMT-E) for the untrained persons. Test composed of question-answer in order to calculate the remembering, caution and calculation structure. All patients SMMTE scores were recorded. In the operation room, patients were applied the standard D-II derivation electrocardiography, heart beat rate, non-invasive arterial pressure, peripheral oxygen saturation (SpO2) and Bispectral Index (BİS) monitorization. Serum sale infusion was started by opening the vascular access with 18-20 gauge cannula. The skin of forehead and the temporal side were cleaned with alcohol cotton for the BİS monitorization. The electrode in the proximal part of the three electrodes of disposable BİS sensor was adhered to the middle of the forehead; the distal electrode to the temporal area on the eye line and the other electrode in between them both were adhered. The BİS values (BİS Monitor, Aspect, USA) were continuously monitored. The Group I (TİVA, n= 20) were received propofol-remifentanil and the Grup II (TİVA+D, n= 20) propofol- remifentanil and additional dexmedetomidine infusion.

Induction of propofol infusion in all two groups was started as firstly 12 mg. kg-1 for the 30 minutes, the second 30 minutes 9 mg. kg-1 and the BIS values were arranged between 40-60 until the end of the operation. At the same time remifentanil infusion 0.5 μg.kg-1 was applied as opioid and arranged according to the tension artery and heart rate. The dexmedetomidine infusion has been started as 0.5 μg.kg-1 without making the loading dose and the dose change was not made. Rocuronium 0.5 mg. kg-1 iv. was applied for the endotracheal intubation. After intubation the carbon dioxide concentration was recorded in all periods.

The patients were ventilated mechanically after the intubation in order to be ETCO2 (end-tidal carbon dioxide) 30-44 mmHg, tidal volume 8-10 mL. kg-1 . In case of tachycardia or hypertension the opioid dose was reduced in case of bradycardia or hypertension while the opioid dose was being increased. Propofol infusion was arranged to be kept in between BİS score 40-50. The effect of the used muscle relaxant was returned by neostigmine 0,05- 0,07 mg. kg-1 i.v. and atropin 0,03 mg. kg -1 i.v. After the operation all patients have been taken to the recovery room.

Then the tests of cognitive function evaluation were repeated as postoperative 2nd hour, 24 hours, 1 week and 1 month.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Cognitive Functions After TIVA With Dexmedetomidine
Study Start Date :
Jan 1, 2008
Actual Primary Completion Date :
Oct 1, 2008
Actual Study Completion Date :
Oct 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: Group 1 (TIVA)

Only propofol (started as firstly 12 mg. kg-1 for the 30 minutes, the second 30 minutes 9 mg. kg-1) and remifentanil infusion (0.5 μg.kg-1)

Drug: Remifentanil
In case of tachycardia or hypertension the opioid dose was reduced, in case of bradycardia or hypertension the opioid dose was increased
Other Names:
  • ultiva
  • Drug: Propofol
    BIS values were arranged 40-60 until the end of operation

    Drug: Rocuronium
    0.5 mg/kg iv for intubation, no change
    Other Names:
  • esmeron
  • Active Comparator: Group 2 (TIVA+D)

    Propofol started as firstly 12 mg. kg-1 for the 30 minutes, the second 30 minutes 9 mg. kg-1) and remifentanil infusion (0.5 μg.kg-1),and also dexmedetomidine infusion (started as 0.5 μg.kg-1 without making the loading dose and the dose change was not made during the operation)

    Drug: Remifentanil
    In case of tachycardia or hypertension the opioid dose was reduced, in case of bradycardia or hypertension the opioid dose was increased
    Other Names:
  • ultiva
  • Drug: Propofol
    BIS values were arranged 40-60 until the end of operation

    Drug: Dexmedetomidine
    0.5 microgram/kg infusion, no changes
    Other Names:
  • precedex
  • Drug: Rocuronium
    0.5 mg/kg iv for intubation, no change
    Other Names:
  • esmeron
  • Outcome Measures

    Primary Outcome Measures

    1. all patients cognitive functions examination by MMSE (Mini Mental State Examination) test [2nd hour]

      The cognitive function evaluation performed by MMSE test at the second hour of the surgery

    2. all patients cognitive functions examination by MMSE (Mini Mental state examination) [change from baseline in cognitive functions at one year]

      The MMSE test evaluation performed by MMSE test at 24th hour, 1 week, 1 year after the surgery

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 60 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • under going lumbar disk hernia operation

    • 20-60 years old

    • ASA (American Society of Anesthesiologists Physical Status classification) classification I-II

    Exclusion Criteria:
    • pregnants

    • Patients with hepatic, renal or neurological diseases and

    • patients using sedative- hypnotic, anticonvulsive and stimulant drugs

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Uludag University Bursa Turkey

    Sponsors and Collaborators

    • Uludag University

    Investigators

    • Study Director: Hulya Bilgin, professor, Uludag University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Hale Aksu Erdost, Specialist, Dokuz Eylul University
    ClinicalTrials.gov Identifier:
    NCT02631135
    Other Study ID Numbers:
    • 2007-21/18
    First Posted:
    Dec 16, 2015
    Last Update Posted:
    Dec 16, 2015
    Last Verified:
    Dec 1, 2015
    Keywords provided by Hale Aksu Erdost, Specialist, Dokuz Eylul University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 16, 2015